Literature DB >> 20409501

Geographic disparity, area poverty, and human papillomavirus vaccination.

Sandi L Pruitt1, Mario Schootman.   

Abstract

BACKGROUND: A human papillomavirus (HPV) vaccine was approved by the Food and Drug Administration for use among women/girls in 2006. Since that time, limited research has examined HPV vaccine uptake among adolescent girls and no studies have examined the role of geographic disparities in HPV vaccination.
PURPOSE: The purpose of this study is to examine geographic disparity in the prevalence of human papillomavirus (HPV) vaccination and to examine individual-, county-, and state-level correlates of vaccination.
METHODS: Three-level random intercept multilevel logistic regression models were fitted to data from girls aged 13-17 years living in six U.S. states using data from the 2008 Behavioral Risk Factor Surveillance System (BRFSS) and the 2000 U.S. census.
RESULTS: Data from 1709 girls nested within 274 counties and six states were included. Girls were predominantly white (70.6%) and insured (74.5%). Overall, 34.4% of girls were vaccinated. Significant geographic disparity across states (variance=0.134, SE=0.065) and counties (variance=0.146, SE=0.063) was present, which was partially explained by state and county poverty levels. Independent of individual-level factors, poverty had differing effects at the state and county level: girls in states with higher levels of poverty were less likely whereas girls in counties with higher poverty levels were more likely to be vaccinated. Household income demonstrated a similar pattern to that of county-level poverty: Compared to girls in the highest-income families, girls in the lowest-income families were more likely to be vaccinated.
CONCLUSIONS: The results of this study suggest geographic disparity in HPV vaccination. Although higher state-level poverty is associated with a lower likelihood of vaccination, higher county-level poverty and lower income at the family level is associated with a higher likelihood of vaccination. Research is needed to better understand these disparities and to inform interventions to increase vaccination among all eligible girls. 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409501      PMCID: PMC3259737          DOI: 10.1016/j.amepre.2010.01.018

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  44 in total

1.  County characteristics and racial and ethnic disparities in the use of preventive services.

Authors:  Maureen R Benjamins; James B Kirby; Stephanie A Bond Huie
Journal:  Prev Med       Date:  2004-10       Impact factor: 4.018

2.  Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression.

Authors:  Klaus Larsen; Juan Merlo
Journal:  Am J Epidemiol       Date:  2005-01-01       Impact factor: 4.897

3.  Should HPV vaccination be mandatory?

Authors:  Joseph De Soto
Journal:  J Fam Pract       Date:  2007-04       Impact factor: 0.493

4.  Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis.

Authors:  Geetanjali D Datta; Graham A Colditz; Ichiro Kawachi; S V Subramanian; Julie R Palmer; Lynn Rosenberg
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

5.  Socioeconomic factors and persistent racial disparities in childhood vaccination.

Authors:  Karen G Wooten; Elizabeth T Luman; Lawrence E Barker
Journal:  Am J Health Behav       Date:  2007 Jul-Aug

6.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

Review 7.  American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.

Authors:  Debbie Saslow; Philip E Castle; J Thomas Cox; Diane D Davey; Mark H Einstein; Daron G Ferris; Sue J Goldie; Diane M Harper; Walter Kinney; Anna-Barbara Moscicki; Kenneth L Noller; Cosette M Wheeler; Terri Ades; Kimberly S Andrews; Mary K Doroshenk; Kelly Green Kahn; Christy Schmidt; Omar Shafey; Robert A Smith; Edward E Partridge; Francisco Garcia
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

8.  Children who have received no vaccines: who are they and where do they live?

Authors:  Philip J Smith; Susan Y Chu; Lawrence E Barker
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  Effect of area poverty rate on cancer screening across US communities.

Authors:  Mario Schootman; Donna B Jeffe; Elizabeth A Baker; Mark S Walker
Journal:  J Epidemiol Community Health       Date:  2006-03       Impact factor: 3.710

10.  National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-05       Impact factor: 17.586

View more
  58 in total

Review 1.  State-of-the-art and future directions in multilevel interventions across the cancer control continuum.

Authors:  Kurt C Stange; Erica S Breslau; Allen J Dietrich; Russell E Glasgow
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

2.  A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination.

Authors:  Laura M Kester; Gregory D Zimet; J Dennis Fortenberry; Jessica A Kahn; Marcia L Shew
Journal:  Matern Child Health J       Date:  2013-07

3.  Hepatitis B vaccination among adolescents 13-17 years, United States, 2006-2012.

Authors:  Peng-jun Lu; David Yankey; Jenny Jeyarajah; Alissa O'Halloran; Laurie Elam-Evans; Stacie M Greby; James A Singleton; Trudy V Murphy
Journal:  Vaccine       Date:  2015-02-25       Impact factor: 3.641

4.  An innovative housing-related measure for individual socioeconomic status and human papillomavirus vaccination coverage: A population-based cross-sectional study.

Authors:  Kathy L MacLaughlin; Robert M Jacobson; Jennifer L St Sauver; Debra J Jacobson; Chun Fan; Chung-Il Wi; Lila J Finney Rutten
Journal:  Vaccine       Date:  2020-07-24       Impact factor: 3.641

5.  Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women.

Authors:  Molly A Feder; Shalini L Kulasingam; Nancy B Kiviat; Constance Mao; Erik J Nelson; Rachel L Winer; Hilary K Whitham; John Lin; Stephen E Hawes
Journal:  J Womens Health (Larchmt)       Date:  2019-07-02       Impact factor: 2.681

6.  A Population-Based Study of Sociodemographic and Geographic Variation in HPV Vaccination.

Authors:  Lila J Finney Rutten; Patrick M Wilson; Debra J Jacobson; Amenah A Agunwamba; Carmen Radecki Breitkopf; Robert M Jacobson; Jennifer L St Sauver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-14       Impact factor: 4.254

7.  Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.

Authors:  Karen A Cullen; Shannon Stokley; Lauri E Markowitz
Journal:  Acad Pediatr       Date:  2014-06-20       Impact factor: 3.107

8.  Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.

Authors:  Megan C Lindley; Philip J Smith; Lance E Rodewald
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

9.  Are HPV vaccination services accessible to high-risk communities? A spatial analysis of HPV-associated cancer and Chlamydia rates and safety-net clinics.

Authors:  Jennifer Tsui; Hector P Rodriguez; Gilbert C Gee; Loraine A Escobedo; Gerald F Kominski; Roshan Bastani
Journal:  Cancer Causes Control       Date:  2013-09-17       Impact factor: 2.506

10.  County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008.

Authors:  Jan M Eberth; Xingyou Zhang; Monir Hossain; Jasmin A Tiro; James B Holt; Sally W Vernon
Journal:  Tex Public Health J       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.